These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 17027303)

  • 21. Strangles: a pathogenic legacy of the war horse.
    Waller AS
    Vet Rec; 2016 Jan; 178(4):91-2. PubMed ID: 26795860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant Streptococcus equi proteins protect mice in challenge experiments and induce immune response in horses.
    Flock M; Jacobsson K; Frykberg L; Hirst TR; Franklin A; Guss B; Flock JI
    Infect Immun; 2004 Jun; 72(6):3228-36. PubMed ID: 15155624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strangles: taking steps towards eradication.
    Waller AS
    Vet Microbiol; 2013 Nov; 167(1-2):50-60. PubMed ID: 23642414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiplex polymerase chain reaction for identification and differentiation of Streptococcus equi subsp. zooepidemicus and Streptococcus equi subsp. equi.
    Alber J; El-Sayed A; Lämmler C; Hassan AA; Weiss R; Zschöck M
    J Vet Med B Infect Dis Vet Public Health; 2004 Dec; 51(10):455-8. PubMed ID: 15606870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strangvac: A recombinant fusion protein vaccine that protects against strangles, caused by Streptococcus equi.
    Robinson C; Frykberg L; Flock M; Guss B; Waller AS; Flock JI
    Vaccine; 2018 Mar; 36(11):1484-1490. PubMed ID: 29398274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modified live Streptococcus equi ('strangles') vaccination followed by clinically adverse reactions associated with bacterial replication.
    Kemp-Symonds J; Kemble T; Waller A
    Equine Vet J; 2007 May; 39(3):284-6. PubMed ID: 17520983
    [No Abstract]   [Full Text] [Related]  

  • 27. Streptococcus equi Infections in Horses: Guidelines for Treatment, Control, and Prevention of Strangles-Revised Consensus Statement.
    Boyle AG; Timoney JF; Newton JR; Hines MT; Waller AS; Buchanan BR
    J Vet Intern Med; 2018 Mar; 32(2):633-647. PubMed ID: 29424487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The molecular basis of Streptococcus equi infection and disease.
    Harrington DJ; Sutcliffe IC; Chanter N
    Microbes Infect; 2002 Apr; 4(4):501-10. PubMed ID: 11932201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An assessment of mucosal immunisation in protection against Streptococcus equi ('Strangles') infections in horses.
    Wallace FJ; Emery JD; Cripps AW; Husband AJ
    Vet Immunol Immunopathol; 1995 Sep; 48(1-2):139-54. PubMed ID: 8533309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigations towards an efficacious and safe strangles vaccine: submucosal vaccination with a live attenuated Streptococcus equi.
    Jacobs AA; Goovaerts D; Nuijten PJ; Theelen RP; Hartford OM; Foster TJ
    Vet Rec; 2000 Nov; 147(20):563-7. PubMed ID: 11104039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of modified-live equine intranasal vaccine pathogens in adult horses using quantitative PCR.
    Harms C; Mapes S; Akana N; Coatti Rocha D; Pusterla N
    Vet Rec; 2014 Nov; 175(20):510. PubMed ID: 25274853
    [No Abstract]   [Full Text] [Related]  

  • 32. Strangles, bastard strangles, vives and glanders: archaeological relics in a genomic age.
    Slater JD
    Equine Vet J; 2003 Mar; 35(2):118-20. PubMed ID: 12638785
    [No Abstract]   [Full Text] [Related]  

  • 33. Antibody kinetics and immune profile analysis of a Streptococcus equi DNA vaccine expressing the FljB and SeM fusion protein in murine and equine models.
    Ma X; Wang C; Zhang B; Xia L; Su Y
    Res Vet Sci; 2019 Aug; 125():82-88. PubMed ID: 31174167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization and immunogenicity of pyrogenic mitogens SePE-H and SePE-I of Streptococcus equi.
    Artiushin SC; Timoney JF; Sheoran AS; Muthupalani SK
    Microb Pathog; 2002 Feb; 32(2):71-85. PubMed ID: 11812213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on Streptococcus equi subsp equi infections.
    Mallicote M
    Vet Clin North Am Equine Pract; 2015 Apr; 31(1):27-41. PubMed ID: 25600455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors associated with likelihood of horses having a high serum Streptococcus equi SeM-specific antibody titer.
    Boyle AG; Sweeney CR; Kristula M; Boston R; Smith G
    J Am Vet Med Assoc; 2009 Oct; 235(8):973-7. PubMed ID: 19827984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efforts to combat strangles recognised.
    Vet Rec; 2012 Nov; 171(21):522. PubMed ID: 23180707
    [No Abstract]   [Full Text] [Related]  

  • 38. Nasal mucosal immunogenicity for the horse of a SeM peptide of Streptococcus equi genetically coupled to cholera toxin.
    Sheoran AS; Artiushin S; Timoney JF
    Vaccine; 2002 Feb; 20(11-12):1653-9. PubMed ID: 11858875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strangles Awareness Week: a new initiative to help stamp out strangles.
    Vet Rec; 2020 Sep; 187(6):e42. PubMed ID: 32895310
    [No Abstract]   [Full Text] [Related]  

  • 40. Development of a novel mucosal vaccine against strangles by supercritical enhanced atomization spray-drying of Streptococcus equi extracts and evaluation in a mouse model.
    Rodrigues MA; Figueiredo L; Padrela L; Cadete A; Tiago J; Matos HA; Gomes de Azevedo E; Florindo HF; Gonçalves LM; Almeida AJ
    Eur J Pharm Biopharm; 2012 Oct; 82(2):392-400. PubMed ID: 22841882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.